LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus

Journal: Nature Communications

Published: 2018-04-16

DOI: 10.1038/s41467-018-03943-0

Affiliations: 18

Authors: 31

Go to article
Institutions FC
Department of Regeneration and Cell Therapy, CABIMER, Spain 0.35
Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM), Spain 0.06
Ulm University Medical Center, Germany 0.06
Amarna Therapeutics B.V. - Granada, Spain 0.06
Department of Cell Dynamics and Signaling, CABIMER, Spain 0.03
Department of Cell Physiology and Metabolism, UNIGE, Switzerland 0.03
Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), Spain 0.03
EPFL Laboratory of Metabolic Signaling, Switzerland 0.03
Clinical Bioinformatics Area, FPS, Spain 0.03
Faculty Diabetes Center, UNIGE, Switzerland 0.03
University Hospital of Geneva (HUG), Switzerland 0.03
Institute of Biomedical Research in Malaga (IBIMA), Spain 0.03
Department of Translational Research and New Technologies in Medicine and Surgery, UNIPI, Italy 0.03
University Hospital of Pisa, UNIPI, Italy 0.03
Department of Clinical and Experimental Medicine, UNIPI, Italy 0.03
Faculty of Health Sciences, UBU, Spain 0.03
Neurix SA, Switzerland 0.03
Apceth Biopharma GmbH, Germany 0.03